» Articles » PMID: 24489983

Tanshinol Attenuates the Deleterious Effects of Oxidative Stress on Osteoblastic Differentiation Via Wnt/FoxO3a Signaling

Overview
Publisher Wiley
Date 2014 Feb 4
PMID 24489983
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

There is now increasing evidence which suggests a pivotal role for oxidative stress in the development and progression of osteoporosis. We confirm herein the protective effects of natural antioxidant Tanshinol against oxidative stress in osteoblastic differentiation and the underlying mechanism. Our results show that hydrogen peroxide (H2O2) leads to accumulation of reactive oxygen species (ROS), decrease in cell viability, cell cycle arrest and apoptosis in a caspase-3-dependent manner, and inhibition of osteoblastic differentiation. Tanshinol reverses these deleterious consequence triggered by oxidative stress. Moreover, under the condition of oxidative stress, Tanshinol suppresses the activation of FoxO3a transcription factor and expressions of its target genes Gadd45a and catalase (CAT) and simultaneously counteracts the inhibition of Wnt signalling and expressions of target genes Axin2, alkaline phosphatase (ALP), and Osteoprotegerin (OPG). The findings are further consolidated using FoxO3a siRNA interference and overexpression of Tcf4. The results illustrate that Tanshinol attenuates oxidative stress via down-regulation of FoxO3a signaling, and rescues the decrease of osteoblastic differentiation through upregulation of Wnt signal under oxidative stress. The present findings suggest that the beneficial effects of Tanshinol may be adopted as a novel therapeutic approach in recently recognized conditions of niche targeting osteoporosis.

Citing Articles

The Roles of Forkhead Box O3a (FOXO3a) in Bone and Cartilage Diseases - A Narrative Review.

Wu Z, Zhan W, Wu L, Yu L, Xie X, Yu F Drug Des Devel Ther. 2025; 19:1357-1375.

PMID: 40034405 PMC: 11874768. DOI: 10.2147/DDDT.S494841.


An electrostatic encapsulation strategy to motivate 3D-printed polyelectrolyte scaffolds for repair of osteoporotic bone defects.

Gao X, Yang J, Liu L, Hu Z, Lin R, Tang L Bioact Mater. 2024; 46:1-20.

PMID: 39719966 PMC: 11665476. DOI: 10.1016/j.bioactmat.2024.12.007.


Tanshinol ameliorates imiquimod-induced psoriasis by inhibiting M1 macrophage polarization through suppression of the notch signaling pathway.

Liu J, Yong S, Yin S, Feng J, Lian C, Chen J Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8745-8758.

PMID: 38832986 PMC: 11522191. DOI: 10.1007/s00210-024-03166-9.


Local Application of Tanshinone IIA protects mesenchymal stem cells from apoptosis and promotes fracture healing in ovariectomized mice.

Cheng S, Hu X, Sun K, Huang Z, Zhao Y, Sun Y J Orthop Surg Res. 2024; 19(1):309.

PMID: 38783358 PMC: 11112815. DOI: 10.1186/s13018-024-04793-x.


KLF transcription factors in bone diseases.

Wang H, Han J, Dmitrii G, Ning K, Zhang X J Cell Mol Med. 2024; 28(8):e18278.

PMID: 38546623 PMC: 10977429. DOI: 10.1111/jcmm.18278.


References
1.
Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T . Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 1994; 127(6 Pt 1):1755-66. PMC: 2120318. DOI: 10.1083/jcb.127.6.1755. View

2.
Suda N, Morita I, Kuroda T, Murota S . Participation of oxidative stress in the process of osteoclast differentiation. Biochim Biophys Acta. 1993; 1157(3):318-23. DOI: 10.1016/0304-4165(93)90116-p. View

3.
Galli C, Passeri G, Macaluso G . FoxOs, Wnts and oxidative stress-induced bone loss: new players in the periodontitis arena?. J Periodontal Res. 2011; 46(4):397-406. DOI: 10.1111/j.1600-0765.2011.01354.x. View

4.
Manolagas S . From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010; 31(3):266-300. PMC: 3365845. DOI: 10.1210/er.2009-0024. View

5.
Krakstad C, Chekenya M . Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer. 2010; 9:135. PMC: 2893101. DOI: 10.1186/1476-4598-9-135. View